Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Omnicell (OMCL)

Omnicell raises 2025 revenue and profit guidance as Q2 revenue rises 5% to $291 million

Mixed Impact 4 of 5 guidance Written later

Omnicell reported second quarter 2025 total revenues of $291 million, up 5% from a year earlier, and GAAP net income of $6 million, or $0.12 per diluted share. Non-GAAP net income fell to $21 million, or $0.45 per share, from $24 million, or $0.51, a year earlier. The company raised its full-year 2025 total revenue, non-GAAP EBITDA and non-GAAP EPS guidance, while reaffirming its product bookings and annual recurring revenue outlook.

Key points

  • Q2 2025 total revenues were $291 million, up $14 million, or 5%, from Q2 2024
  • GAAP net income was $6 million ($0.12 per diluted share), versus $4 million ($0.08) a year earlier; non-GAAP net income was $21 million ($0.45), versus $24 million ($0.51)
  • Full-year 2025 total revenue guidance is now $1.130 billion to $1.160 billion; non-GAAP EBITDA guidance is $130 million to $145 million; non-GAAP EPS guidance is $1.40 to $1.65
  • Operating cash flow was $43 million in Q2 2025, down from $59 million in Q2 2024

The filing

CompanyOmnicell (OMCL)
Form8-K, current report
Filed with the SECJul 31, 2025, 6:33 AM ET
Accession number0000926326-25-000016

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.